Effects of Adlay Hull and Testa Ethanolic Extracts on the Growth of Uterine Leiomyoma Cells

Shih-Min Hsia, Kuan-Hsien Lin, Wenchang Chiang, Chi-Hao Wu, Tzong-Ming Shieh, Tsui-Chin Huang, Hsin-Yuan Chen, Li-Chun Lin

Research output: Contribution to journalArticle

Abstract

Uterine leiomyoma has become a significant health concern affecting one in forth women in reproductive age in Taiwan, according to the Ministry of Health and Welfare. The associated symptoms can lead to reduced life quality and women ultimately seeking for surgical intervention. Adlay extract possesses anti-tumor activity and has shown to inhibit sarcoma cell proliferation and tumor progression. In present study, viability of ELT3 cells was tested to screen for different fractions of adlay extracts, as well as various phenolic compounds and flavonoids. The active adlay fractions and compounds were then tested on primary human leiomyoma cells. Cell cycle profiles of ELT3 cells were analyzed in order to determine the possible cause of growth-inhibition. Results showed that AHE-EA, ATE-Hex, and ATE-EA were able to inhibit the proliferation of ELT3 and primary leiomyoma cells. Among the tested compounds, Quercetin, nobiletin and eriodictyol, significantly decreased the viability of ELT3 and primary leiomyoma cells. Quercetin induced cell cycle arrest of ELT3 cells at Sub-G1 and G2/M phases. Adlay extracts exhibit growth-inhibitory effects on uterine leiomyoma cells. These effects may result from to the combined actions of different compounds, indicating a possibility of matrix effect from the compounds in adlay extract. Therefore, adlay extracts may be considered a feasible alternative therapeutic agent for leiomyoma.
Original languageEnglish
Pages (from-to)85-96
Number of pages12
Journal調適醫學
Volume9
Issue number2
DOIs
Publication statusPublished - 2017

Fingerprint

Leiomyoma
Growth
Quercetin
G2 Phase
Health
Cell Cycle Checkpoints
Taiwan
Flavonoids
Sarcoma
Cell Division
Neoplasms
Cell Survival
Cell Cycle
Quality of Life
Cell Proliferation

Keywords

  • ueterine leiomyoma
  • adlay
  • quercetin

Cite this

Effects of Adlay Hull and Testa Ethanolic Extracts on the Growth of Uterine Leiomyoma Cells. / Hsia, Shih-Min; Lin, Kuan-Hsien; Chiang, Wenchang; Wu, Chi-Hao; Shieh, Tzong-Ming; Huang, Tsui-Chin; Chen, Hsin-Yuan; Lin, Li-Chun.

In: 調適醫學, Vol. 9, No. 2, 2017, p. 85-96.

Research output: Contribution to journalArticle

Hsia, Shih-Min ; Lin, Kuan-Hsien ; Chiang, Wenchang ; Wu, Chi-Hao ; Shieh, Tzong-Ming ; Huang, Tsui-Chin ; Chen, Hsin-Yuan ; Lin, Li-Chun. / Effects of Adlay Hull and Testa Ethanolic Extracts on the Growth of Uterine Leiomyoma Cells. In: 調適醫學. 2017 ; Vol. 9, No. 2. pp. 85-96.
@article{017f7c952b26455382ad85fe2c038183,
title = "Effects of Adlay Hull and Testa Ethanolic Extracts on the Growth of Uterine Leiomyoma Cells",
abstract = "Uterine leiomyoma has become a significant health concern affecting one in forth women in reproductive age in Taiwan, according to the Ministry of Health and Welfare. The associated symptoms can lead to reduced life quality and women ultimately seeking for surgical intervention. Adlay extract possesses anti-tumor activity and has shown to inhibit sarcoma cell proliferation and tumor progression. In present study, viability of ELT3 cells was tested to screen for different fractions of adlay extracts, as well as various phenolic compounds and flavonoids. The active adlay fractions and compounds were then tested on primary human leiomyoma cells. Cell cycle profiles of ELT3 cells were analyzed in order to determine the possible cause of growth-inhibition. Results showed that AHE-EA, ATE-Hex, and ATE-EA were able to inhibit the proliferation of ELT3 and primary leiomyoma cells. Among the tested compounds, Quercetin, nobiletin and eriodictyol, significantly decreased the viability of ELT3 and primary leiomyoma cells. Quercetin induced cell cycle arrest of ELT3 cells at Sub-G1 and G2/M phases. Adlay extracts exhibit growth-inhibitory effects on uterine leiomyoma cells. These effects may result from to the combined actions of different compounds, indicating a possibility of matrix effect from the compounds in adlay extract. Therefore, adlay extracts may be considered a feasible alternative therapeutic agent for leiomyoma.",
keywords = "ueterine leiomyoma, adlay, quercetin",
author = "Shih-Min Hsia and Kuan-Hsien Lin and Wenchang Chiang and Chi-Hao Wu and Tzong-Ming Shieh and Tsui-Chin Huang and Hsin-Yuan Chen and Li-Chun Lin",
year = "2017",
doi = "10.4247/AM.2017.ABH176",
language = "English",
volume = "9",
pages = "85--96",
journal = "調適醫學",
issn = "2076-944X",
publisher = "Society of Adaptive Science in Taiwan & Airiti Press Inc.",
number = "2",

}

TY - JOUR

T1 - Effects of Adlay Hull and Testa Ethanolic Extracts on the Growth of Uterine Leiomyoma Cells

AU - Hsia, Shih-Min

AU - Lin, Kuan-Hsien

AU - Chiang, Wenchang

AU - Wu, Chi-Hao

AU - Shieh, Tzong-Ming

AU - Huang, Tsui-Chin

AU - Chen, Hsin-Yuan

AU - Lin, Li-Chun

PY - 2017

Y1 - 2017

N2 - Uterine leiomyoma has become a significant health concern affecting one in forth women in reproductive age in Taiwan, according to the Ministry of Health and Welfare. The associated symptoms can lead to reduced life quality and women ultimately seeking for surgical intervention. Adlay extract possesses anti-tumor activity and has shown to inhibit sarcoma cell proliferation and tumor progression. In present study, viability of ELT3 cells was tested to screen for different fractions of adlay extracts, as well as various phenolic compounds and flavonoids. The active adlay fractions and compounds were then tested on primary human leiomyoma cells. Cell cycle profiles of ELT3 cells were analyzed in order to determine the possible cause of growth-inhibition. Results showed that AHE-EA, ATE-Hex, and ATE-EA were able to inhibit the proliferation of ELT3 and primary leiomyoma cells. Among the tested compounds, Quercetin, nobiletin and eriodictyol, significantly decreased the viability of ELT3 and primary leiomyoma cells. Quercetin induced cell cycle arrest of ELT3 cells at Sub-G1 and G2/M phases. Adlay extracts exhibit growth-inhibitory effects on uterine leiomyoma cells. These effects may result from to the combined actions of different compounds, indicating a possibility of matrix effect from the compounds in adlay extract. Therefore, adlay extracts may be considered a feasible alternative therapeutic agent for leiomyoma.

AB - Uterine leiomyoma has become a significant health concern affecting one in forth women in reproductive age in Taiwan, according to the Ministry of Health and Welfare. The associated symptoms can lead to reduced life quality and women ultimately seeking for surgical intervention. Adlay extract possesses anti-tumor activity and has shown to inhibit sarcoma cell proliferation and tumor progression. In present study, viability of ELT3 cells was tested to screen for different fractions of adlay extracts, as well as various phenolic compounds and flavonoids. The active adlay fractions and compounds were then tested on primary human leiomyoma cells. Cell cycle profiles of ELT3 cells were analyzed in order to determine the possible cause of growth-inhibition. Results showed that AHE-EA, ATE-Hex, and ATE-EA were able to inhibit the proliferation of ELT3 and primary leiomyoma cells. Among the tested compounds, Quercetin, nobiletin and eriodictyol, significantly decreased the viability of ELT3 and primary leiomyoma cells. Quercetin induced cell cycle arrest of ELT3 cells at Sub-G1 and G2/M phases. Adlay extracts exhibit growth-inhibitory effects on uterine leiomyoma cells. These effects may result from to the combined actions of different compounds, indicating a possibility of matrix effect from the compounds in adlay extract. Therefore, adlay extracts may be considered a feasible alternative therapeutic agent for leiomyoma.

KW - ueterine leiomyoma

KW - adlay

KW - quercetin

U2 - 10.4247/AM.2017.ABH176

DO - 10.4247/AM.2017.ABH176

M3 - Article

VL - 9

SP - 85

EP - 96

JO - 調適醫學

JF - 調適醫學

SN - 2076-944X

IS - 2

ER -